Concepedia

Katy L. Blake

KL

6

Publications

308

Citations

6

H-Index

2008

Active since

Affiliations

University of Leeds(Current)

Novartis (China)

Novartis (Switzerland)

Katy L. Blake is an author at University of Leeds specializing in medicine, antibiotics, and clinical microbiology.

Top concepts

Publications per year

2008–2012

6

Publications

6

The nature of <i>Staphylococcus aureus</i> MurA and MurZ and approaches for detection of peptidoglycan biosynthesis inhibitors

Katy L. Blake, Alex J. O’Neill, Dominique Mengin‐Lecreulx et al. · Molecular Microbiology · 2009 · 88 citations · Full text

<i>In Vitro</i> Studies Indicate a High Resistance Potential for the Lantibiotic Nisin in Staphylococcus aureus and Define a Genetic Basis for Nisin Resistance

Katy L. Blake, Christopher P. Randall, Alex J. O’Neill · Antimicrobial Agents and Chemotherapy · 2011 · 81 citations · Full text

, , +20

Transposon library screening for identification of genetic loci participating in intrinsic susceptibility and acquired resistance to antistaphylococcal agents

Katy L. Blake, Alex J. O’Neill · Journal of Antimicrobial Chemotherapy · 2012 · 72 citations · Full text

2-Aminotetralones: Novel inhibitors of MurA and MurZ

Colin J. Dunsmore, Keith Miller, Katy L. Blake et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 35 citations

, , +9

Benzothioxalone derivatives as novel inhibitors of UDP-N-acetylglucosamine enolpyruvyl transferases (MurA and MurZ)

Keith Miller, Colin J. Dunsmore, Jennifer A. Leeds et al. · Journal of Antimicrobial Chemotherapy · 2010 · 22 citations · Full text

Rows per page

1–5 of 6